Society of Hematologic Oncology Insider news

Dr. Iacoboni on improving CAR T-cell therapy outcomes in lymphoma

13 min · 17. mar. 2026
Billede af episoden Dr. Iacoboni on improving CAR T-cell therapy outcomes in lymphoma

Description

Gloria Iacoboni, MD, PhD, a hematologist at Vall d’Hebron University Hospital in Barcelona, Spain, spoke with Dr. James Day, a clinical research training fellow at UCL in London, during this SOHO Insider podcast episode recorded at the inaugural SOHO UK 2026 meeting. The meeting was held in London March 3 and 4 at the Royal College of Physicians in London.   Dr. Iacoboni discussed strategies to improve outcomes in high-grade lymphoma, focusing on improved patient selection, the emergence of dual-targeted CAR T-cell products (CD19/CD20), and how circadian rhythms might impact infusion efficacy.  Follow more news from SOHO UK [https://sohoinsider.com/category/meetings-conferences/soho-uk/].

Comments

0

Be the first to comment

Sign up now and become a member of the Society of Hematologic Oncology Insider news community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

15 episodes

episode Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer artwork

Dr. Nirav Shah on the next iteration in CAR-T cell therapy in blood cancer

In this SOHO Insider podcast, host Megan Melody, MD, from Tampa General Hospital, spoke with Nirav Shah, MD, professor at the Medical College of Wisconsin, on news from the 2026 Tandem Meetings, including updates on dual-targeted CAR T-cell results in CLL and interim phase 2 data on zamtocabtagene autoleucel (zamto-cel) in in transplant-ineligible patients with DLBCL. Of dual-targeting CAR-T cell therapies, he said, “I think this is the next iteration in CAR. Zamtocabtagene is one of four 20/19 CARs under development and if you look at the data for all of them, they look to be highly efficacious, better than our standard CD19-CAR.” Listen to more podcasts on sohoinsider.com.  [https://sohoinsider.com/category/soho-insider-podcast/]

7. maj 202615 min
episode Why clinicians should lead hospitals, according to Prof. Amanda Goodall artwork

Why clinicians should lead hospitals, according to Prof. Amanda Goodall

Prof. Amanda Goodall, director of the Executive Master’s in Medical Leadership (EMML), a specialized MSc degree from Bayes Business School offering advanced leadership training to medical doctors, joined SOHO Insider podcast host Prof. Christopher Fox, a professor of hematology at Nottingham University Hospitals NHS Trust, for a discussion on expert leadership in healthcare. According to Prof. Goodall, expert leadership is the idea that organizations perform best when leaders are experts in the core work of the institution. As part of this work, she runs an executive master’s program in medical leadership, designed to help physicians develop the skills needed to lead healthcare organizations while maintaining credibility as clinicians. Her research argues that in healthcare this means placing experienced, high-performing physicians in leadership roles rather than relying primarily on generalist managers. Many doctors, she noted, are interested in leadership because they want to drive meaningful change and improve patient care, but historically they have had limited access to formal leadership training. The podcast was taped during the inaugural meeting of SOHO UK [https://sohoinsider.com/category/meetings-conferences/soho-uk/], where Prof. Goodall gave a talk after dinner on the topic. Learn about the Executive Master’s in Medical Leadership (EMML) program [https://www.bayes.citystgeorges.ac.uk/study/degree-apprenticeships/executive-msc-in-medical-leadership].

10. mar. 20266 min